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At least two cellular processes are required for corneal epithelium homeostasis and wound repair: cell proliferation and cell-
cell adhesion. These processes are delicately balanced to ensure the maintenance of normal epithelial function. During wound
healing, these processes must be reprogrammed in coordination to achieve a rapid re-epithelialization. Basonuclin (Bnc1) is
a cell-type-specific transcription factor expressed mainly in the proliferative keratinocytes of stratified epithelium (e.g., corneal
epithelium, epidermis and esophageal epithelium) and the gametogenic cells in testis and ovary. Our previous work suggested
that basonuclin could regulate transcription of ribosomal RNA genes (rDNA) and genes involved in chromatin structure,
transcription regulation, cell-cell junction/communication, ion-channels and intracelllular transportation. However, basonu-
clin’s role in keratinocytes has not been demonstrated in vivo. Here we show that basonuclin-null mutation disrupts corneal
epithelium homeostasis and delays wound healing by impairing cell proliferation. In basonuclin-null cornea epithelium, RNA
polymerase I (Pol I) transcription is perturbed. This perturbation is unique because it affects transcripts from a subset of rDNA.
Basonuclin-null mutation also perturbs RNA polymerase II (Pol II) transcripts from genes encoding chromatin structure proteins
histone 3 and HMG2, transcription factor Gli2, gap-junction protein connexin 43 and adheren E-cadherin. In most cases,
a concerted change in mRNA and protein level is observed. However, for E-cadherin, despite a notable increase in its mRNA
level, its protein level was reduced. In conclusion, our study establishes basonuclin as a regulator of corneal epithelium
homeostasis and maintenance. Basonuclin likely coordinates functions of a subset of ribosomal RNA genes (rDNA) and a group
of protein coding genes in cellular processes critical for the regulation of cell proliferation.
Citation: Zhang X, Tseng H (2007) Basonuclin-Null Mutation Impairs Homeostasis and Wound Repair in Mouse Corneal Epithelium. PLoS ONE 2(10):
e1087. doi:10.1371/journal.pone.0001087
INTRODUCTION
The adult mouse cornea is comprised of three tissue layers: a surface
of stratified epithelium, a collagenous stroma underneath and an
inner endothelium. The corneal epithelium is a self-renewing tissue,
whose maintenance requires continuous cell proliferation through-
out life. In addition toits lightrefraction function, cornealepithelium
also serves as a protective barrier to the external environment. This
barrier function makes corneal epithelium susceptible to a variety of
mechanicalandchemicalinjuries.Conceivably,acornealepithelium
that can rapidly repair wounds would convey selective advantages to
animals, whose survival relies on vision.
Two cellular processes are essential for corneal epithelium
maintenance and wound repair: cell proliferation and cell
adhesion. In normal renewing, corneal epithelium stratification
(thickness) is maintained by a balance between cell proliferation at
the basal layer and cell shedding at the surface. This life-long
continuous upward cell flux is driven by the corneal epithelium
stem cells resided in the limbus region [1–4]. Accompanying the
surface-ward cell migration is a differentiation process, which
involves, among other things, remodeling of cell-cell junction and
communication (e.g., formation of tight junctions, gap junctions
and ion channels in the suprabasal wing cells) [5–9]. In wound
healing, however, these processes are modified in order to achieve
a rapid re-epithelialization [10]. In the commonly used wound
healing model (i.e., epithelial debridement at central cornea), the
healing process is divided into three sequential and partially
overlapping steps: cell migration reduces and eventually covers the
wound surface, cell proliferation provides cells to rebuild the tissue
and tissue remodeling to restore the stratified epithelium [9,11–16].
Basonuclin (Bnc1) is a zinc finger protein with highly restricted
tissue/cell distribution [17,18]. It is present in abundance in only
two types of cells: basal keratinocytes of stratified epithelium (e.g.,
corneal epithelium and epidermis), and the reproductive germ cells
of testis and ovary (i.e., oocytes and spermatogenic cells) [19,20].
In mouse corneal epithelium, basonuclin expression is restricted to
the basal keratinocytes in the central cornea; it is not detected in
the limbal region, suggesting its absence in the multi-potent stem
cells [21]. Basonuclin protein appears in the corneal basal
keratinocyte at post-natal day 4, first in a few cells and then
spread to the entire basal cell population on day 20 [21]. Thus, in
early neonatal period, basonuclin expression coincides with active
cellular proliferation, which peaks at day 10 prior to eye opening
[15]. This expression pattern and the basal-cell location of
basonuclin strongly suggested its role in cell proliferation [18,21].
Basonuclin is a transcription factor with multiple functions.
Biochemically, DNase I footprinting showed that basonuclin
interacted with ribosomal RNA gene (rDNA) promoter at three
highly conserved binding sites in human and mouse [22–25].
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loci during mitosis [23], a typical behavior of transcription factors
for Pol I, which is solely responsible for transcribing rDNA.
Furthermore, basonuclin zinc fingers were shown to act as
a dominant-negative agent to inhibit Pol I transcription in mouse
oocytes [24]. These observations strongly suggest that basonuclin
plays a role in Pol I transcription regulation. Basonuclin is unique
among the known regulators of Pol I transcription in that its
expression is cell-type-specific and it functions in regulating
a subset of rDNA. Such a novel ability was first hinted in our
study of basonuclin-deficient oocytes. Run-on assays showed that
in basonuclin-deficient oocytes, the number of Pol I transcription
foci was reduced by ,25%, and the transcriptional activity of the
remaining foci, as judged by BrU incorporation, was not changed
[26]. Similarly, we showed in HaCaT cells, a transformed human
keratinocyte line, that basonuclin interacted with rDNA promoters
that differed from those bound with UBF, a ubiquitous Pol I
transcription regulator [25]. These observations support the
notion that basonuclin regulates a subset of rDNA and lead us
to search for rDNA variants that are regulated cell-type-
specifically. As a result, we isolated seven rDNA variants (v-
rDNAs) and showed, for the first time, that they were regulated
differentially in different tissues (Tseng et al. submitted).
Another major difference of basonuclin and a dedicated Pol I
transcription factor (e.g., UBF) is that basonuclin is also abundant
in nucleoplasm and can interact with Pol II promoters. Indeed,
a recent bioinformatic study detected basonuclin binding sites in
the promoter regions of more than 20 genes, which belong to
pathways involved in chromatin structure, transcription, cell-cell
adhesion/communication, ion-channels and intracellular protein
transportation [27]. The dual function of basonuclin to regulate
two groups of genes, (i.e., Pol I- and Pol II-transcribed) suggests
that it coordinates the function of these genes. Thus, basonuclin is
likely a coactivator-like regulator. The concept of coactivator is
that a regulator can mobilize multiple pathways to achieve
a cellular function [28]. The coactivators were initially thought to
function as adaptors for transcription factors [29], but their actions
have now expanded to chromatin modification and remodeling,
transcription initiation, elongation, RNA splicing and protein
degradation. The range of target pathways of coactivators has also
increased to encompass cell development, proliferation, energy-
expenditure and carbohydrate- metabolism [30–32]. These coacti-
vators are therefore coordinators of multiple cellular pathways.
Despite these advances in understanding basonuclin function, its
requirement in keratinocyte function has not been studied in vivo.
Here we report the construction of a basonuclin-null mouse and
characterization of basonuclin-null corneal epithelium. We show
that basonuclin-null mutation impairs keratinocyte proliferation.
We present in vivo evidence supporting the notion that basonuclin
regulates transcription of a subset of rDNA and a selective group
of protein-coding genes. We propose that basonuclin is a critical
regulator for corneal epithelium homeostasis.
RESULTS
Construction of Bnc1-null mouse
We designed a basonuclin conditional-null allele, in which Exon 4
wastargetedfordeletioninthepresenceofCrerecombinase(Fig. 1).
The conditional-null allele consisted of Exon 4 and a neo gene, which
served as a selective marker (Fig. 1A). The Exon 4 and the neo were
flanked by LoxP sites, where Cre recombinase-mediated deletion
occurred. The deletion created a stop-codon in the remaining
reading frame topreventtranslation ofsequencebeyond the deletion
site. Thus, the null-mutation removed approximately 90% of
basonuclin protein sequence, which included all six zinc fingers
and the nuclear localization signal. Such deletion would prevent the
remaining 10% sequence from entering the nucleus [33].
The targeting construct was transduced into ES cells (R1 strain,
[34]) via electroporation. The transduced cells were subjected to
G418 (neo) selection. In approximately 3% of the G418-resistant ES-
cell clones, the conditional-null allele (fl-neo) replaced the normal
allele. This conclusion was based on observing the predicted 7.2 kb
and 9.2 kb Eco RI fragments by Southern analysis using a 59 (P5)
and a 39 (P3) probes, respectively (Fig. 1A, B). Germ line
transmission of the conditional-null allele was shown by Southern
blots (Fig. 1B) and by PCR (Fig. 1C). Bnc1 (+/2)m i c ew e r e
obtained by mating the Bnc1 (+/fl-neo) with a ZP3-Cre mouse,
which expressed Cre recombinase only in the oocytes [35]. As
expected, approximately 50% progeny were Bnc1 (+/2), which
were apparently normal and fertile. The Bnc1 (+/2)m i c ew e r e
crossed to obtain basonuclin-null mice (Bnc1 2/2). PCR detected
Bnc1 2/2 progeny (Fig. 1C), which were born at a reduced
frequency (not shown) and the surviving pups developed normally
except infertile. (The infertility phenotype will be described
elsewhere.) In the total RNA of basonuclin-null tail, RT-PCR
detected no mRNA sequence from Exon 4 (Fig. 1D). Furthermore,
immunocytochemistry confirmed the absence of basonuclin protein
in the basal keratinocytes of corneal epithelium, where it was
normally expressed (Fig 1E). We thus successfully ablated the
basonuclin gene. Because this whole-body basonuclin-knockout
mouse was viable, we used them for the experiments described here
and did not generate a corneal-specific basonuclin-null mutant.
Basonuclin-null corneal epithelium is thinner
Corneal epithelium was present in basonuclin-null mice, suggest-
ing basonuclin was not critically required for its development. We
therefore examined corneal epithelium homeostasis in 12-week old
mice, when corneal epithelial development had largely completed
[36]. Histology (hematoxylin and eosin, H&E) showed a 14%
thinning of basonuclin-null corneal epithelium, which was on
average 30.6 microns thick compared with the control’s 34.6
microns (for each genotype n=6, p,0.001)(Fig. 2A, B, C). By
counting 4,6-diamino-2-phenylindole (DAPI)-stained nuclei, we
found that the thinner epithelium contained 15% fewer cells
compared with the control (i.e., Bnc1 +/+). The average cell
density was 11668 (cell number per 0.3 mm corneal epithelium in
length) in basonuclin-null corneal epithelium compared to that of
139611 in the control (n=6, p,0.05) (Fig. 2D, E, F). In
contrast, no difference in cell density was seen in corneal stroma of
the mutant and the control (n=6)(Fig. 2G).
The reduced cell number could be the result of a decrease in cell
proliferation or an increase in apoptosis. To discern these
possibilities, we examined the number of Ki67-positive cells by
immunostaining. Ki67 antigen was a marker for cell proliferation;
it was expressed in every stage of the cell cycle, but absent in cells
that had exited permanently from the cell cycle. The number of
Ki67-positive cells was scored across the entire section of corneal
epithelium. Corneas from six mice of each genotype (Bnc1 +/+
and 2/2) were examined. The average number of Ki67-positive
cells was 135625 per section in basonuclin-null epithelium,
compared with 181617 in the control, (n=6, p,0.05) (Fig. 2H,
I, J), which translated into a 25% decrease in the mutant. TUNEL
assay was used to assess apoptosis. A very small number (,3) of
TUNEL-positive cells were detected per corneal section in both
basonuclin-null and control epithelium (not shown), indicating that
loss of basonuclin did not lead to a significant change in the rate of
apoptosis. Therefore, the thinning of basonuclin-null corneal
epithelium was likely caused by a reduced cell proliferation.
Bnc1-Null Corneal Epithelium
PLoS ONE | www.plosone.org 2 October 2007 | Issue 10 | e1087Figure 1. Generation of basonuclin-null mouse. A, A graphic depiction of the knockout strategy. The targeted locus (,18.7 kb) of the basonuclin
gene is shown at the top. Restriction sites relevant to cloning and detection of the conditional allele are indicated. Exons are depicted as black boxes
and the Southern probes (P5 and P3) are indicated as short blue lines. Shown below the targeted locus is the structure of basonuclin conditional-null
allele, which consists of a neo gene upstream from the Exon 4. The neo gene and the Exon 4 are flanked by loxP sites. To facilitate the detection of the
conditional-null allele, two new Eco RI sites are generated with the insertion of the lox P sites. Upon Eco RI digestion, the wild type allele produces
a single 18.7 kb fragment, whereas that of the conditional-null allele, two fragments of sizes 7.2 kb (detected by 59 probe) and 9.2 kb (39 probe). The
null-allele, which is generated after the excision of the neo and the Exon 4 by Cre recombinase, is shown below the conditional-null allele. PCR
primers, depicted as circle-ended arrows, are designed to facilitate genotyping. B, Successful homologous recombination of the targeting vector was
verified by Southern blots. Genomic DNAs from ES cells and founder mice tails were digested with Eco RI and analyzed by Southern blot using 59 (P5)
and 39 (P3) probes (A, blue lines) outside the targeted region (defined by the lox P sites). The genotypes are indicated at the top of the Southern
image, molecular weight markers are shown to the right and the probes at the bottom. f, the allele with inserted loxP. C, The null allele was generated
by mating the female conditional knockout mice with ZP3-Cre males to create a Bnc1 (flox/+);ZP3-Cre female, which was then crossed with normal
males. The genotypes of Bnc1 (+/+) (f/+), (f/f), (+/2), and (2/2) mice were identified by PCR and the deletion of Exon 4 was verified by PCR with
primers indicated in A. In the PCR, all three primers were present, primers 2 and 3 detected the wild type and conditional alleles and primers 1 and 3
detected the null allele. The primer extension step was limited so that primers 1 and 3 could not produce a fragment with the wild type and the
conditional allele. floxed, loxP-inserted. D, The absence of basonuclin mRNA was demonstrated with two pairs (A and D) of PCR primers targeting
different regions of the Exon 4 (top panel). Tail RNAs of three Bnc1 (2/2) mice from two litters were assayed. The litters and genotypes are indicated
at the top of the gel image and molecular weight of the amplicon on the right. E, The absence of basonuclin protein was demonstrated by
immunostaining. The arrow shows an example of a basonuclin-positive cell. A dotted line indicates the position of basement membrane. Epi,
epithelium; Str, stroma.
doi:10.1371/journal.pone.0001087.g001
Bnc1-Null Corneal Epithelium
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wound healing
To investigate if reduced proliferation during normal epithelial
homeostasis also affected wound repair, we used a corneal
epithelium debriment model to compare the re-epithelialization
rate between basonuclin-null mice and the control in vivo. The
debriment wound removed the epithelium without damaging the
underlining basement membrane. Such an epithelial wound was
generally repaired (re-epithelialized) within 72 hours in normal
mice [11,37]. The wounded (denuded) area was visualized by
fluorescein staining (Fig. 3A) and measured at regular interval to
assess the healing progress. In the first 24 hours post wounding,
the denuded area was reduced at similar rate between basonuclin-
null and the control corneal epithelia. A significant delay in re-
epithelialization, however, was observed in basonuclin-null
epithelium at 40 and 72 hours post wounding (Fig. 3A). At
40 hours, the wound area in basonuclin-null cornea was three
times that of the control (three mice per genotype, or n=3,
p,0.05), and at 72 hours, nearly six times (n=3, p,0.01)
(Fig. 3A), indicating a slower healing in the mutant at the later
stage of re-epithelialization. Epithelium re-epithelialization was
usually completed in two phases: first, cell migration reduced the
wounded area and then cell proliferation regenerated the
epithelium. The significant delay in the latter stage of wound
healing suggested a defective cell proliferation. We assessed cell
proliferation during wound healing by BrdU labeling, which
detected cells in the S phase of the cell cycle. During the first six
hours after wounding, the numbers of BrdU labeled cells in the
control and basonuclin-null mice were similar to their pre-
wounding value (0 hours), indicating cell proliferation had not
been activated (Fig. 3B). At 12 hours post-wounding, the number
of BrdU-positive cells began to increase in the control, but not in
basonuclin-null epithelium (n=3, p,0.01). A significant increase
in BrdU incorporation was seen in basonuclin-null cells at
24 hours. The number of BrdU-positive cells was, however, still
below that in the control (n=3, p,0.01). These data suggested
that there was a delay in the onset of cell proliferation in
basonuclin-null epithelium, which was consistent with the delay in
the later stage of re-epithelialization in basonuclin-null cornea.
Thus, basonuclin-null mutation impaired cell proliferation of
corneal keratinocytes, which could account for both the thinning
as well as the delayed wound healing of corneal epithelium.
Basonuclin-null mutation reduced transcripts from
a subset of rDNA
The molecular cloning of seven v-rDNAs (Tseng et al., 2007,
submitted) and the construction of the basonuclin-null mouse
model provided us with the first opportunity to test the notion that
a transcription factor could regulate a subset of rDNA. We had
developed a set of PCR assays to detect the expression of each
Figure 2. Basonuclin-null corneal epithelium is thinner and contains fewer cells. Compared with the histology (H & E) of normal cornea (A),
basonuclin-null cornea (B) is thinner (a bracket shows the definition of epithelial thickness. C, Measurements of the corneal epithelium thickness show
the thinning caused by basonuclin-null mutation is highly significant (n=6, p,0.001). DAPI staining of nuclear DNA (the arrow shows an example)
shows that compared with the control (D), basonuclin-null (E) corneal epithelium has ,15% fewer cells (F) (n=6, p,0.05), whereas the cell numbers
in stroma are the same (G). The reduced epithelial cell number is likely caused by a reduced cell proliferation. Compared with the control (H), the
basonuclin-null (I) epithelium contained ,25% fewer Ki67 antigen-positive cells (J) (n=6, p,0.05). The arrow in H shows an example of Ki67-positive
cells. The statistical analyses represent the average of six mice for each genotype. The code of statistical significance is given at the lower right corner.
All images are of the same magnification. Scale bar in B equals 30 micron.
doi:10.1371/journal.pone.0001087.g002
Bnc1-Null Corneal Epithelium
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polymorphisms (SNP) located in the 59 external-transcribed-spacer
(59-ETS) of the 47S pre-ribosomal RNA (pre-rRNA). Using the
variant-specific PCR assay, the expression profiles of the seven v-
rDNAs were examined in corneal epithelium of basonuclin-null
and control mice (Fig. 4). For each genotype, total RNAs from
four corneal epithelium sheets were pooled and each assay was
performed three times (n=3). Our results showed that corneal
epithelium expressed five v-rDNAs (I, II, IV, VI and VII) (Fig. 4A,
B). This was the first detection of v-rDNA VII transcript, which
had not been detected in RNA from all major mouse tissues, and
hence v-rDNA VII was previously classified as transcriptionally
silent. Basonuclin-null mutation affected the expression of three of
the seven v-rDNAs. The expression of v-rDNA I, II and VI was
reduced in basonuclin-null mice compared with the control (i.e.,
Bnc1 +/+). Quantification showed that v-rDNAs I and II
transcripts, which could not be distinguished by the assay, were
reduced by ,25% (n=3, p,0.05) and that of VI more than 80%
(n=3, p,0.05)(Fig. 4A, B). The result of v-rDNA VI was
confirmed by a real-time PCR assay (Fig. 4, C, D, E). For
a technical reason (insufficient specificity), the result of v-rDNA
I+II was not repeated with real-time PCR (not shown). These
results were consistent with our previous reports that basonuclin-
deficiency affected a subset of rDNA expression [25,26]. Our
results also identified, for the first time, the rDNA variants that
were affected by basonuclin-null mutation.
Basonuclin-null mutation perturbed the expression
of a number of protein-coding genes
The basonuclin target genes transcribed by RNA Pol II were
clustered in at least four pathways, i.e., chromatin structure,
transcription regulation, ion channels, and cell-cell adhesion
[26,27]. Among these four pathways, we selected 11 target genes
for examination by real-time RT-PCR. Each basonuclin target
pathway was represented by at least two genes. The selection was
also based on target genes’ perturbation in basonuclin-deficient
oocytes [26], basonuclin’s occupancy of the target promoter [27]
and the availability and quality of antibodies against the protein
encoded by the target gene. To ensure that we detected only
mRNA sequences, the primers were chosen to locate in two
different exons. Because basonuclin’s role in regulating rDNA
transcription and hence its potential in regulating translation, we
measured the level of protein encoded by the mRNAs that we
examined by RT-PCR. For each genotype, RNA from four
corneal epithelia was pooled and assayed for three times.
We detected consistent and significant mRNA changes in two
pathways, chromatin structure and cell adhesion. Two mRNAs in
the chromatin structure pathways were up-regulated in basonu-
clin-null corneal epithelium; the mRNAs of histone 3 H2A
(H3)(NM_178218) was up by ,70% (n=3, p,0.01) and that of
the high-mobility group 2 (HMG2, NM_008252), ,40% (n=3,
p,0.05). In cell adhesion pathways, the mRNA of E-cadherin
(NM_009864) was up-regulated by ,50%. Other perturbations in
mRNAs were similarly detected in the pathways of transcription
regulation and ion channel (Fig. 5), although these changes were
not statistically significant.
Assessing perturbation in proteins by immunocytochemistry and
immunoblotting confirmed the changes detected in most of the
mRNA, including those that were not statistically significant.
Although we aimed to produce immunocytochemical and
immunoblotting data for each protein, some antibodies failed to
work in one procedure. Immunocytochemistry detected a stronger
presence of histone 3 H2A in the basonuclin-null-corneal
epithelium than in the keratocytes of the stroma (Fig. 6A).
Similarly, immunoblotting showed an increase in HMG2 in
basonuclin-null corneal epithelium (Fig. 6B). Both agreed with
the RT-PCR results. Immunocytochemistry also showed a consis-
tent down-regulation of Gli 2 protein, an effector of the Sonic
Hedgehog (Shh) pathway. The decreased immunostaining agreed
with the reduction of Gli2 mRNA detected by RT-PCR, albeit the
mRNA change was not statistically significant, suggesting a specific
but marginal decrease of Gli2 function in the basonuclin-null
corneal epithelium.
Figure 3. Wound healing is delayed in basonuclin-null corneal
epithelium. A, the upper panel shows representative images of the
control (+/+) and basonuclin-null (2/2) eyes at different time points
pre- and post-wounding. The images of –5 min show the eyes prior to
wounding. The denuded surface of corneal regions was topically
stained with fluorescein (green). In the 0 hr images, the denuded area is
marked with a dashed line to illustrate the size of the original wound.
The lower panel shows the quantification (n=3) of the wounded area
(presented as percentage of the original wound area). Note that the
slower healing of basonuclin-null epithelium is observed at 40 hr and 72
hr post wounding, but not before. B, BrdU labeling showed a delayed
onset of DNA replication in basonuclin-null corneal epithelium during
wound healing. The bar graph represents the average number of BrdU
labeled cells per section. Two sections from each of three mice were
examined (n=3). * p,0.05, ** p,0.01.
doi:10.1371/journal.pone.0001087.g003
Bnc1-Null Corneal Epithelium
PLoS ONE | www.plosone.org 5 October 2007 | Issue 10 | e1087Figure 4. Variant-rDNA expression in basonuclin-null corneal epithelium. A, A set of variant-specific RT-PCRs were used to measure the expression
of seven v-rDNAs in the control and basonuclin-null corneal epithelia. The primer specificity (I to VII) is indicated on the left of the gel image; beta-
actin PCR was included to monitor the relative quantity and integrity of RNA preparation. The templates are indicated above the gel image: i to vii,
cloned v-rDNA controls; m, molecular weight marker (100 bp ladder), RNAs from control (+/+) and basonuclin-null (2/2) epithelia. B, The v-rDNA
expression was quantified by measuring the fluorescence of stained PCR product and analyzed statistically. The v-rDNA expression level is expressed
as percentage of that of the beta-actin PCR product (100%) (bar graphs). Each value was the average of 3 measurements (n=3) of a mixture of RNA
from four corneal epithelia of each genotype. The results of regular PCR were confirmed by quantitative PCR (real-time PCR or qPCR). C and D, Control
experiments were performed to ensure the specificity of qPCR for v-rDNA IV (C) and VI (D). The Ct values of cloned templates are plotted; light gray,
non-specific template and black, specific template. A lower Ct value signifies a higher specificity. E, RNA samples similar to that shown in A are
measured by qPCR. The v-rDNA expression values are displayed as percentages of the reference gene (beta-actin). * p,0.05, ** p,0.01.
doi:10.1371/journal.pone.0001087.g004
Bnc1-Null Corneal Epithelium
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proteins. By RT-PCR, the transcript of Connexin 43 (Cx43),
a gap-junction protein, was decreased nearly 20% in basonuclin-
null corneal epithelium. This decrease was confirmed by
immunoblot, which showed a 60% decrease of Cx43 protein
(Fig. 6A, B). Immunostaining study showed a punctuated pattern
of Cx43 in the basal cell layer of corneal epithelium. Scoring the
number of Cx43 foci showed that the average number of foci in
the control was 253640, whereas that in the basonuclin-null
mouse was 212659 (n=7, P,0.01), a 16% decrease in the
mutant. Therefore, Cx43 function was impaired by basonuclin-
null mutation. Our data showed previously that the promoter of
desmoglein 1 (DSG1) gene, a component of desmosome,
contained a basonuclin binding site [27] and DSG1 mRNA was
upregulated 4-fold in basonuclin-deficient oocytes [26]. However,
in basonuclin-null corneal epithelium, the levels of DSG1 mRNA
and protein were not significantly altered (Fig. 6A), suggesting
tissue/cell-type variation in response to basonuclin-deficiency.
The most interesting alteration was observed in adherens. We
showed previously that one of basonuclin target genes was in the
adheren family, i.e., proto-cadherin 18 (PCDH18), and the
expressions of members of this family were perturbed in
basonuclin-deficient oocytes [26,27]. In corneal epithelium,
quantitative PCR showed that basonuclin-null mutation caused
an 18% decrease in PCDH18 mRNA level, and a 50% increase in
the amount of E-cadherin mRNA (n=3, P,0.01) (Fig. 5), but the
distribution of E-cadherin, visualized by immunofluorescence, was
not significantly changed (Fig. 6A). Interestingly, the immunos-
taining intensity suggested a reduction of E-cadherin protein level,
contrary to the increase in its mRNA level (Fig. 5 and 6B). The
contradictory changes of E-cadherin mRNA (up-regulated) and
protein (down-regulated) were further investigated by quantitative
analysis. Immunoblotting showed a highly significant two-fold
decrease in E-cadherin protein (n=3, p,0.01) (Fig. 6B). The
non-concerted change of E-cadherin mRNA and protein
suggested that the mRNA up-regulation was a compensatory
adjustment in response to the decrease in the quantity of protein.
Because E-cadherin’s critical role in signal transduction and its
linking role in cell adhesion and proliferation [6,8,38–40], the
impaired E-cadherin seen in basonuclin-null corneal epithelium
could at least in part explain the reduced cell proliferation in
homeostasis as well as in wound repair.
DISCUSSION
Using a basonuclin-null mouse, we demonstrate for the first time
the requirement of basonuclin in keratinocyte proliferation.
Previously, based on basonuclin’s basal location in the stratified
epithelium and its presence in every stage of the cell cycle,
including G0, we proposed that basonuclin played a role in
keratinocyte proliferation [18–20]. Our study presented here
confirms basonuclin’s role in keratinocyte proliferation; it also
suggests that basonuclin plays a role in the regulatory mechanism
of cellular proliferation, but not the cell division process itself. This
conclusion is deduced from the observation that basonuclin-null
mutation does not affect neonatal corneal keratinocyte pro-
liferation. During the formation of corneal epithelium in neonatal
mouse (P1 to P14), corneal keratinocytes proliferate at a very high
rate, and basonuclin expression is seen at the beginning of this
proliferation period (i.e., around P3–P4) [21]. The coincidence of
basonuclin’s appearance and the rapid keratinocyte proliferation
led us to postulate that basonuclin played a role in the high rate
cell proliferation during corneal epithelium development. We were
baffled, however, by the persistent high level basonuclin expression
through out the adulthood after developmentally related pro-
liferation had subsided post-eye-opening. Our study of basonuclin-
null corneal epithelium provides a satisfactory resolution to this
dilemma; basonuclin is required for the homeostasis but not
Figure 5. Transcript (mRNA) level of basonuclin-target genes in basonuclin-null corneal epithelium. Relative mRNA level of basonuclin-target
genes was analyzed by real-time PCR using total RNAs isolated from the control and basonuclin-null corneal epithelia. Each RNA preparation was
a mixture of four corneal epithelia of the same genotype and the analysis was performed in triplicates (n=3). The average level of expression was
normalized to beta-actin. The bar graph represents the average of three RNA preparations and their statistical variation (s.d.). The gene identity is
given below each bar and the pathway of the genes indicated with white letters on a black background. * P,0.05, ** P,0.01.
doi:10.1371/journal.pone.0001087.g005
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the neonatal development of this epithelium is not retarded,
suggesting that basonuclin is not critically required in this process.
Furthermore, this observation suggests that the defect of
basonuclin-null mutation is not in the cell division mechanism.
Cell proliferation is down-regulated after eye-opening around P14
in mouse, and is maintained at a low level during the rest of the life
span [15,21]. Our study suggests that basonuclin is required for
maintaining an optimal level of cell proliferation necessary for
corneal epithelium homeostasis, because we observed both
a reduction in cell number and the proliferative (Ki67-positive)
cells in the basonuclin-null corneal epithelium. An additional
defect of basonuclin-null keratinocytes was revealed in the wound-
healing process. In this case, the timing of the on-set of cellular
proliferation is delayed, which suggest a signaling defect in
mobilizing keratinocytes to respond the wound. The notion of
a signaling defect is consistent with our hypothesis that basonuclin
is a coordinator of multiple pathways. The slower mobilization of
cellular proliferation therefore is likely due to the lack of
coordination of various pathways participating in the mobilization
process. Another logical conclusion is that the signaling (or
coordination) mechanism controlling cell proliferation in neonatal
corneal epithelium development differs from that functioning in
adulthood for the homeostasis of this tissue.
The clear corneal phenotype of basonuclin (Bnc1)-null mutation
suggests that it and basonuclin-2 (Bnc2), the second member of the
basonuclin family, have non-overlapping functions. Bnc2, a closely
related homolog of Bnc1, has a much wider tissue distribution
than that of Bnc1 [41,42]; and both are reportedly co-present in
keratinocytes and oocytes [26,41–43]. In Bnc1-deficient oocytes,
in which Bnc2 expression is not affected, we also observed a clear
phenotype (i.e., maternal effect), suggesting in mouse oocytes Bnc1
and 2 also have non-overlapping functions [26]. This notion is
supported by a recent observation that Bnc1 and 2 reside in
different intracellular compartments [44]. These observations,
however, do not exclude the possibility that the two proteins share
Figure 6. Basonuclin-null mutation affects level of proteins in basonuclin-targeted pathways. A, Immunostaining shows perturbation of protein
level in basonuclin-null corneal epithelium. The antibody specificity is indicated on the left of immunofluorescent images and the genotype on the
top. Arrowheads show examples of a positively stained cell in the epithelium and arrows that in the stroma and endothelium. Dotted-lines indicate
the surface of the endothelium. e, epithelium, s, stroma, ed, endothelium. B, Immunoblot of selected proteins whose mRNA were perturbed by
basonuclin-null mutation. The antibody specificity is shown on the right of the blot image and the genotype on the top. The apparent molecular
weight of each detected protein is given to the left. C, Quantification of the Immunoblot analyses. The values are average of three measurements
(n=3). **, p,0.01; ***, p,0.005.
doi:10.1371/journal.pone.0001087.g006
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fingers and DNA targets [41]. Our current model systems (Bnc1-
null and Bnc1-deficiency) are not suitable for addressing the issue
of overlapping functions of the two proteins. The answer to this
question awaits the development of a Bnc2-null mutation and the
generation of a Bnc1-Bnc2 double null mutant.
Several previous reports and our study suggest cell proliferation
is a major process in maintaining corneal thickness. The thinner
corneal epithelium in basonuclin-null mouse is similar to the
phenotype of several recently described mouse models (i.e., null
mutants of Pax6, KLF4, AP2-alpha and HMGN1). The thinning
of corneal epithelium suggests that homeostasis is perturbed by
these null mutations. However, the causes of this perturbation
appear quite different. For example, in adult SEY(+/2),
a heterozygotes of Pax6-null [8], the thinning of cornea epithelium
is likely due to a compromised cell adhesion, which results in large
gaps between epithelial cells and a change in desmosomal
junctions [8]. In another example, the conditional null mutation
of Kru ¨ppel-like transcription factor-4 (KLF4) reduces the corneal
epithelium to only three to four cell layers by causing excessive
sloughing [45]. The third example concerns the conditional
deletion of AP-2alpha (Le-AP-2alpha), which leads to a variable
thickness of corneal epithelium (2 to 10 cell layers), and a thinner
and discontinuous basement membrane [39]. The null mutation of
HMGN1, a member of the high-mobility group (HMG) proteins,
gives rise to corneal epithelium thinning, which appears to be the
consequence of an impaired keratinocyte differentiation program
[38]. Notably, in the aforementioned four null mutants (i.e., SEY
(+/2), KLF4-null, Le-AP-2alpha-null and HMGN1), an up-
regulation of proliferation in corneal epithelia is invariably
observed, suggesting the existence of a feedback loop that regulates
corneal thickness [8,39]. When corneal epithelium becomes
thinner due to deficiency in cell adhesion or other causes, cell
proliferation is increased to compensate. Our analysis of
basonuclin-null corneal epithelium provides the first evidence
from another angle (i.e., down-regulation of cell proliferation) to
support this model. Based on this analysis, we propose that under
normal homeostasis, cell proliferation is constantly adjusted to
counterbalance occasional perturbation in corneal thickness
(Fig. 7). This proposal implies a monitoring mechanism of
corneal homeostasis and a feedback mechanism to tune cell
proliferation rate according to corneal thickness. A regulatory role
of basonuclin in fine-tuning cell proliferation is consistent with
basonuclin’s location in basal keratinocytes of stratified epithelium.
Although the molecular nature of such mechanisms remains to
be elucidated, the aforementioned studies suggest a central role of
E-cadherin in maintaining the homeostasis of corneal epithelium.
The histological and cell biological manifestations of the
aforementioned null-mutations are different, some affecting cell
adhesion, and others cell differentiation or cell proliferation,
suggesting they impair distinctive aspects of corneal epithelium
homeostasis. Remarkably, they all perturb the expression of E-
cadherin [8,38,39,45](this work), suggesting this protein is at the
pivotal point of regulation of corneal epithelial homeostasis. E-
cadherin is indeed capable of influencing both cell adhesion and
nuclear events and other pathways through its interaction with
beta-catenin and EphA2 receptor tyrosine kinase [46–49]. E-
cadherin/beta-catenin complex is also regulated by tyrosine
phosphorylation [49] and is a target of Wnt signaling pathway
[50]. The convergence of a wide range of interactions on E-
cadherin is consistent with a role of a sensor and information
integrator in intercellular and intracellular events (Fig. 7). A
perplexing observation is that in most cases, a down-regulation of
E-cadherin function leads to an increase in proliferation, but we
found that basonuclin-null mutation resulted in a down-regulation
of E-cadherin and a decrease in proliferation.
Although there is a strong correlation of E-cadherin function
perturbation and the thinning of corneal epithelium, the un-
derlying molecular alterations of these null-mutations (i.e., Pax6,
KLF4, AP-2alpha, HMGN1 and Bnc1), which lead to changes in
E-cadherin function, are likely different. In a sense, basonuclin is
unique because none of the other aforementioned null-mutations
has been shown to regulate rDNA transcription. In our
examination of the v-rDNA expression profile in corneal
epithelium, we made two novel findings. First, we established
the v-rDNA expression profile in corneal keratinocytes. We found
that v-rDNA VII, whose transcript was absent in most of the
tissues (Tseng et al., submitted), was expressed in cornea
Figure 7. A model of maintenance of corneal epithelial homeostasis. The model asserts that cell proliferation and cell adhesion are major processes
and E-cadherin a molecular regulator in maintaining corneal epithelium homeostasis. The model also proposes a regulatory feedback loop in
controlling corneal epithelial thickness. Any perturbation (e.g., thinning) in corneal thickness would be counterbalanced by adjustment in the rate of
cell proliferation. The model is based on previous reports on null mutations of Pax6, KFL4, AP2alpha, HMGN1 and this work (Bnc1) (See text for the
description).
doi:10.1371/journal.pone.0001087.g007
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basonuclin-null mutation (v-rDNA I, II and VI). These findings
support the notion that cell-type-specific regulation of rDNA
relates to the differential usage of a subset of rDNA [25,51].
However, currently it is not understood why v-rDNAs are
expressed differentially in various tissues, or whether these v-
rDNAs encode different ribosomal RNA (rRNA). The lack of
knowledge in this area precludes an understanding of why
basonuclin can regulate both Pol I and Pol II transcription and
why it regulates a subset of rDNA. Nevertheless, our data strongly
suggest that basonuclin-null mutation impairs the expression of E-
cadherin. Our results show that the amount of E-cadherin protein
was reduced in basonuclin-null corneal epithelium but its mRNA
level was increased. It can be argued that the decrease in the
amount of E-cadherin protein is not due to an impairment of
transcription and basonuclin-null keratinocytes are capable of
increasing production of E-cadherin mRNA, probably in an
attempt to compensate for the reduced protein level. The defect
thus appears to be post-transcriptional and likely translational,
because of basonuclin’s role in rRNA synthesis and ribosomal
biogenesis. The implication of this interpretation is that basonu-
clin-null mutation affects E-cadherin translation selectively,
because we did not detect contradictory changes in mRNA and
protein levels in other genes (e.g., Gli2, HMG2 and Cx43).
Therefore, the mechanism, by which basonuclin-null mutation
perturbs E-cadherin expression, warrants future investigation.
In summary, we describe the construction of the first
basonuclin-null mouse model and the characterization of its
corneal epithelium. Basonuclin-null mutation impairs regulation of
corneal keratinocyte proliferation, which leads to perturbation in
epithelium thickness and delay in wound re-epithelialization. Our
data is consistent with the notion that basonuclin regulates
pathways requiring both Pol I and II transcription. Importantly,
our result confirms that basonuclin regulates a subset of rDNA,
and suggests the identity of basonuclin’s target v-rDNA. Based on
reports by others and this study, we propose a regulatory feedback
loop in maintaining corneal epithelium thickness, and that
basonuclin and E-cadherin are important regulators in corneal
epithelium homeostasis (thickness).
MATERIALS AND METHODS
Generation of basonuclin-null mutant mice
The exon’ 4 of the basonuclin gene, which encodes the critical zinc
fingers and the nuclear localization signal, was targeted for
excision by the Cre recombinase. The targeting vector, which was
constructed by ET recombination [52] with a 12.7kb genomic
sequence, was introduced into 129Sv/R1 ES cells [34] by
electroporation. Homologous recombination was detected by
Southern hybridization. Two independently isolated Bnc1 (fl-
neo/+) clones were injected into C57BL/6J blastocysts at the
Transgenic & Chimeric Mouse Facility at PENN. One clone was
germ-line transmitted. Chimeric males were crossed with C57BL/
6J females to generate Bnc1 (fl-neo/+) mice. Bnc1 (+/2) mice
were obtained by crossing a normal male with a Bnc1 (fl-neo/+:
ZP3-Cre) female according to the scheme described in Fig. 2a of
[35]. Southern hybridization and PCR analysis confirmed the
genotype (for PCR primers, see Table S1). Bnc1 (+/2) mice were
maintained on a 129Sv/Sv-CP/C57BL/6J hybrid genetic back-
ground, and used for generating Bnc1 (2/2).
Tissue Preparations
All animal procedures were performed in accordance with the
ARVO Statement for the Use of Animals in Ophthalmic and
Vision Research. The littermates (Bnc1 +/+) of basonuclin-null
mice were used as control. For RNA or protein extraction, eye
globes of 12-week old mice were dissected and the corneas were
soaked in 20 mM EDTA at 37uC for 1 hr. The epithelium was
gently pealed off and frozen immediately in liquid nitrogen. For
histology, immunocytochemical staining or apoptosis assay, whole
eye globes were surgically removed from 12-week old mice after
euthanization and immediately embedded in O.C.T. (Tissue-
TekH, Sakura Finetec USA, Inc, Torrance, CA) and frozen or
fixed in alcoholic formalin [53] at 4uC overnight before being
processed for serial dehydration and paraffin embedding.
RNA Isolation and PCR
Total RNA was isolated from a mixture of four corneal epithelium
sheets using TRIzol Reagent (Invitrogen, Carlsbad, CA) according
to the manufacturer’s instructions. For v-rDNA expression study,
2 mg total RNA was reverse transcribed with random primers
using the SuperScript First-Strand Synthesis System of Invitrogen.
Each variant-specific PCR was performed with a unique pair of
primers, which conveyed the specificity. For each v-rDNA, PCRs
were always performed together as a set, which was comprised of
specificity controls using cloned v-rDNA as templates, and the
sample RNAs. This scheme ensures that each sample RNA is
assayed with the required specificity and no cross-detection of v-
rDNA occurs. The cycling conditions were also optimized so that
all variant-specific PCRs ran with similar efficiency. The primer
sequences and PCR conditions will be provided upon request.
For mRNA transcription assay, specific primers were designed
for each target gene using Primer3 software (http://primer3.
sourceforge.net/) and the cDNA sequence in GenBank (Table S2).
Total RNA (1 mg) was reverse-transcribed with oligo-dT primers
using the SuperScript First-Strand Synthesis System. The resulting
single-stranded cDNAs were quantified by real-time PCR on
a DNA Engine OPTICON2 (MJ Research, Cambridge, MA) with
DyNAmo SYBR Green qPCR Kit (F-400S, New England
BioLabs, Ipswich, MA). Beta-actin mRNA was used as internal
reference. Thermocycling parameters were 95uC 10 minutes, then
40 cycles of 94uC for 30 seconds, 60uC for 40 seconds, 72uC for
40 seconds. Each sample was analyzed in triplicate, the average of
which was normalized against the expression level of beta-actin
before statistical analysis.
Immunoblotting
Total protein was extracted from two corneal epithelium sheets of
each mouse and lysed in RIPA buffer (i.e., 1% NP-40, 0.5%
sodium deoxycholate, 0.1% SDS, 5mM EDTA) with 100 ng/ml
protease inhibitor cocktail (Roche, Indianapolis, IN). Protein
concentration was determined using the Bio-Rad Protein Assay
(Bio-Rad Laboratories, Hercules, CA). Proteins were separated on
a SDS-PAGE (4,15% gradient Tris-HCL, Bio-Rad Laboratories)
and transfered to a PVDF membrane using a semi-dry
electrophoretic transfer device (Bio-Rad Laboratories) and the 3-
buffer system (Millipore, Billerica, MA). The membrane was
blocked with 5% non-fat dry milk (Bio-Rad Laboratories) in Tris-
buffered saline at room temperature for 1 hour and incubated
with primary antibody at 4uC overnight. The membrane was
washed and incubated with one of the secondary antibodies,
depending on the origin of the primary antibody. The secondary
antibodies were anti-rabbit, anti-mouse, or anti-rat horseradish
peroxidase-conjugated (1:5000, GE Healthcare, Piscataway, NJ).
The immunocomplex was visualized using an ECL kit (Amer-
sham/GE Healthcare). The following primary antibodies were
used, anti-Cx43 (1:2000, Sigma-Aldrich Corp), anti-E-cadherin
Bnc1-Null Corneal Epithelium
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CA) and anti-beta-tubulin (1:10000, Sigma-Aldrich Corp).
Histology and DAPI Staining
Five-micron paraffin sections were stained with hematoxylin and
eosin (H&E) for histological analysis. Slides were counterstained
with DAPI and photographed using a Nikon Eclipse TE2000-U
microscope and a Nikon D1 camera. The number of DAPI-
stained nuclei of each cornea was determined at the central cornea
(4006field, or approximate 0.3 mm). Six mice of each genotype
were analyzed.
Immunofluorescence staining
Six-micron cryosections were fixed for 5 minutes each in methanol
(220 ˚C) and acetone (220 ˚C). Sections were permeabilized by
0.01% Triton X-100 before incubation with primary antibody at
4 ˚C overnight. The following primary antibodies were used: anti-
basonuclin (1:30) [25], anti-E-cadherin (1:100). Five-micron
paraffin sections were de-paraffinized, re-hydrated and then
washed in PBS. After antigen un-masking treatment, sections
were blocked with 5% normal goat serum and incubated with
primary antibody at 4 ˚C overnight. The antibodies used are as
follows: anti-Cx43 (1:500), anti-DSG1 (1:400) [54], anti-Gli2 (1:50,
Abcam, Cambridge, MA), anti-Ki67 (1:50, Vector Laboratories,
Burlingame, CA). The next day, slides were washed in PBS
containing 0.1% NP-40 and incubated with a secondary antibody
(anti-rabbit-Alexa Fluor 488, anti-rat-Alexa Fluor 488, anti-
mouse-Alexa Fluor 594, Invitrogen) at room temperature for
1 hour. All sections were mounted in anti-fade mounting medium
with DAPI (Vector Laboratory) to reveal nuclear staining. For
each experiment, a section was stained without primary antibody
to serve as a negative control. All staining was documented as
described in Histology and DAPI staining. Particle analysis
function of the Image J software (version 1.36b, NIH) was used
to analyze Cx43 foci. Sections from six mice of each genotype
were analyzed.
Apoptosis Assay
TUNEL (TdT-mediated dUTP nick end labeling) assay on
paraffin sections was carried out with the In Situ Cell Death
Detection Kit, Fluorescein (Roche) according to the manufac-
turer’s instruction. Slides were mounted in anti-fade medium with
DAPI and examined with the Nikon fluorescence microscope.
Corneal Epithelium Wounding and Re-
epithelialization
Control and basonuclin-null mice (11 to 12 weeks old) were
anesthetized by an intraperitoneal injection of 80 mg/Kg
ketamine hydrochloride and 16 mg/Kg xylazine. Residual eye
reflexes were blocked by topical application of 0.5% proparacaine
hycrochloride (Alcon Laboratories, Fort Worth, TX) to the
corneal surface. A punch (Acuderm Inc., Ft. Lauderdale, FL)
was used to mark a 2 mm diameter circular area at the center of
the cornea under a dissecting microscope. The corneal epithelium
was debrided with an Algerbrush corneal rust ring remover with
a 0.5 mm burr (Katena Products Inc., Denville, NJ). Antibiotic
ointment was applied to the eyes after surgery. The epithelial
lesions of both the control and basonuclin-null eyes were topically
stained with fluoress (Akorn, Buffalo Grove, IL) and photographed
at various time points post-wounding to monitor re-epithelializa-
tion. The circumference of the wound margin was traced and the
wound area was calculated. The data are presented as (A0-A)/
A0)*100, in which, A is the wound area at a given post-wounding
time point and A0, the wound area at time 0. Some wounded eyes
were removed after BrdU injection to examine the onset of DNA
replication (see below).
DNA Replication Assay
Mice were injected intraperitoneally with BrdU at a dose of
20 mg/g body weight and euthanized by CO2 inhalation
120 minutes post-injection. Eye globes were dissected and
processed for 5 mm paraffin sections. The sections were treated
with proteinase K for 10 minutes at 37 ˚C followed by incubation in
2N HCl for 50 minutes at 37 ˚C. The slides were blocked in 5%
BSA, and incubated with a rat anti-BrdU antibody (AbD Serotec,
Raleigh, NC) at 4 ˚C overnight. The BrdU labeling was visualized
by an anti-rat-IgG-Alexo Fluro488 antibody (Invitrogen). The
number of BrdU-positive cells was scored in three corneas for each
genotype (n=3).
Statistical Analysis
Two-tailed Student’s t-tests (Excel, Microsoft, Redmond, WA) was
used in analyzing the quantitative PCR data, the cell number
scoring, the number of Ki67-positive cells. Chi-square tests were
employed to analyze the foci of Cx43. Null hypotheses were
rejected whey p,0.05. All quantification data are presented as
mean6sd.
SUPPORTING INFORMATION
Table S1 PCR primers
Found at: doi:10.1371/journal.pone.0001087.s001 (0.03 MB
DOC)
Table S2 PCR primers
Found at: doi:10.1371/journal.pone.0001087.s002 (0.03 MB
DOC)
ACKNOWLEDGMENTS
The authors wish to thank Drs Andras Nagy, Reka Nagy, Janet Rossant,
Wanda Abramow-Newerly and John Roder for the mouse ES cells (R1),
Dr Jean Richa of the Transgenic and Chimeric Mouse Facility at the
University of Pennsylvania.
Author Contributions
Conceived and designed the experiments: HT. Performed the experiments:
XZ. Analyzed the data: HT XZ. Wrote the paper: HT.
REFERENCES
1. Cotsarelis G, Cheng SZ, Dong G, Sun TT, Lavker RM (1989) Existence of slow-
cycling limbal epithelial basal cells that can be preferentially stimulated to
proliferate: implications on epithelial stem cells. Cell 57: 201–209.
2. Tseng SC (1989) Concept and application of limbal stem cells. Eye 3 (Pt 2):
141–157.
3. Lavker RM, Tseng SC, Sun TT (2004) Corneal epithelial stem cells at the limbus:
looking at some old problems from a new angle. Exp Eye Res 78: 433–446.
4. Sun TT, Lavker RM (2004) Corneal epithelial stem cells: past, present, and
future. J Investig Dermatol Symp Proc 9: 202–207.
5. Sugrue SP, Zieske JD (1997) ZO1 in corneal epithelium: association to the
zonula occludens and adherens junctions. Exp Eye Res 64: 11–20.
6. Anderson SC, Stone C, Tkach L, SundarRaj N (2002) Rho and Rho-kinase
(ROCK) signaling in adherens and gap junction assembly in corneal epithelium.
Invest Ophthalmol Vis Sci 43: 978–986.
Bnc1-Null Corneal Epithelium
PLoS ONE | www.plosone.org 11 October 2007 | Issue 10 | e10877. Ban Y, Dota A, Cooper LJ, Fullwood NJ, Nakamura T, et al. (2003) Tight
junction-related protein expression and distribution in human corneal
epithelium. Exp Eye Res 76: 663–669.
8. Davis J, Duncan MK, Robison WG Jr, Piatigorsky J (2003) Requirement for
Pax6 in corneal morphogenesis: a role in adhesion. J Cell Sci 116: 2157–2167.
9. Danjo Y, Gipson IK (1998) Actin ‘purse string’ filaments are anchored by E-
cadherin-mediated adherens junctions at the leading edge of the epithelial
wound, providing coordinated cell movement. J Cell Sci 111 (Pt 22): 3323–3332.
10. Lu L, Reinach PS, Kao WW (2001) Corneal epithelial wound healing. Exp Biol
Med (Maywood) 226: 653–664.
11. Chen JJ, Tseng SC (1990) Corneal epithelial wound healing in partial limbal
deficiency. Invest Ophthalmol Vis Sci 31: 1301–1314.
12. Stepp MA, Spurr-Michaud S, Gipson IK (1993) Integrins in the wounded and
unwounded stratified squamous epithelium of the cornea. Invest Ophthalmol
Vis Sci 34: 1829–1844.
13. Chung EH, Hutcheon AE, Joyce NC, Zieske JD (1999) Synchronization of the
G1/S transition in response to corneal debridement. Invest Ophthalmol Vis Sci
40: 1952–1958.
14. Saika S, Shiraishi A, Liu CY, Funderburgh JL, Kao CW, et al. (2000) Role of
lumican in the corneal epithelium during wound healing. J Biol Chem 275:
2607–2612.
15. Zieske JD (2004) Corneal development associated with eyelid opening. Int J Dev
Biol 48: 903–911.
16. Saika S, Muragaki Y, Okada Y, Miyamoto T, Ohnishi Y, et al. (2004) Sonic
hedgehog expression and role in healing corneal epithelium. Invest Ophthalmol
Vis Sci 45: 2577–2585.
17. Tseng H, Green H (1992) Basonuclin: A keratinocyte protein with multiple
paired zinc fingers. Proc Natl Acad Sci USA 89: 10311–10315.
18. Tseng H, Green H (1994) Association of basonuclin with ability of keratinocytes
to multiply and with absence of terminal differentiation. J Cell Biol 126:
495–506.
19. Tseng H (1998) Basonuclin, a zinc finger protein associated with epithelial
expansion and proliferation. Frontiers in Bioscience 3: 985–988.
20. Green H, Tseng H (2005) Basonuclin: A zinc finger protein of epithelial cells and
reproductive germ cells. In: Iuchi S, Kuldell N, eds. Zinc Finger Proteins: From
Atomic Contact to Cellular Function. Georgetown, Texas/New York, New
York: Landes Bioscience/Eurekah.com; Kluwer Academic/Plenum Publishers.
pp 207–212.
21. Tseng H, Matsuzaki K, Lavker RM (1999) Basonuclin in murine corneal and
lens epithelia correlates with cellular maturation and proliferative ability.
Differentiation 65: 221–227.
22. Iuchi S, Green H (1999) Basonuclin, a zinc finger protein of keratinocytes and
reproductive germ cells, binds to the rRNA gene promoter. Proc Natl Acad
Sci U S A 96: 9628–9632.
23. Tseng H, Beigel JA, Brown RS (1999) Basonuclin is associated with the
ribosomal RNA genes on human keratinocyte mitotic chromosomes. J Cell Sci
112.
24. Tian Q, Kopf GS, Brown RS, Tseng H (2001) Function of basonuclin in
increasing transcription of the ribosomal RNA genes during mouse oogenesis.
Development 128: 407–416.
25. Zhang S, Wang J, Tseng H (2007) Basonuclin regulates a subset of ribosomal
RNA genes in HaCaT cells. PLoS ONE 2: e902.
26. Ma J, Zeng F, Schultz RM, Tseng H (2006) Basonuclin: a novel mammalian
maternal effect gene. Development 133: 2053–2062.
27. Wang J, Zhang S, Schultz RM, Tseng H (2006) Search for basonuclin target
genes. Biochem Biophys Res Commun 348: 1261–1271.
28. O’Malley BW (2006) Molecular biology. Little molecules with big goals. Science
313: 1749–1750.
29. Naar AM, Lemon BD, Tjian R (2001) Transcriptional coactivator complexes.
Annu Rev Biochem 70: 475–501.
30. Picard F, Gehin M, Annicotte J, Rocchi S, Champy MF, et al. (2002) SRC-1
and TIF2 control energy balance between white and brown adipose tissues. Cell
111: 931–941.
31. Smith CL, O’Malley BW (2004) Coregulator function: a key to understanding
tissue specificity of selective receptor modulators. Endocr Rev 25: 45–71.
32. Louet JF, Coste A, Amazit L, Tannour-Louet M, Wu RC, et al. (2006)
Oncogenic steroid receptor coactivator-3 is a key regulator of the white
adipogenic program. Proc Natl Acad Sci U S A 103: 17868–17873.
33. Iuchi S, Green H (1997) Nuclear localization of basonuclin in human
keratinocytes and the role of phosphorylation. Procl Natl Acad Sci USA 94:
7948–7953.
34. Nagy A, Rossant J, Nagy R, Abramow-Newerly W, Roder JC (1993) Derivation
of completely cell culture-derived mice from early-passage embryonic stem cells.
Proc Natl Acad Sci U S A 90: 8424–8428.
35. de Vries WN, Binns LT, Fancher KS, Dean J, Moore R, et al. (2000) Expression
of Cre recombinase in mouse oocytes: a means to study maternal effect genes.
Genesis 26: 110–112.
36. Collinson JM, Morris L, Reid AI, Ramaesh T, Keighren MA, et al. (2002)
Clonal analysis of patterns of growth, stem cell activity, and cell movement
during the development and maintenance of the murine corneal epithelium. Dev
Dyn 224: 432–440.
37. Huang AJ, Tseng SC (1991) Corneal epithelial wound healing in the absence of
limbal epithelium. Invest Ophthalmol Vis Sci 32: 96–105.
38. Birger Y, Davis J, Furusawa T, Rand E, Piatigorsky J, et al. (2006) A role for
chromosomal protein HMGN1 in corneal maturation. Differentiation 74:
19–29.
39. Dwivedi DJ, Pontoriero GF, Ashery-Padan R, Sullivan S, Williams T, et al.
(2005) Targeted deletion of AP-2alpha leads to disruption in corneal epithelial
cell integrity and defects in the corneal stroma. Invest Ophthalmol Vis Sci 46:
3623–3630.
40. Zhang L, Deng M, Kao CW, Kao WW, Xia Y (2003) MEK kinase 1 regulates c-
Jun phosphorylation in the control of corneal morphogenesis. Mol Vis 9:
584–593.
41. Romano RA, Li H, Tummala R, Maul R, Sinha S (2004) Identification of
Basonuclin2, a DNA-binding zinc-finger protein expressed in germ tissues and
skin keratinocytes. Genomics 83: 821–833.
42. Vanhoutteghem A, Djian P (2004) Basonuclin 2: an extremely conserved
homolog of the zinc finger protein basonuclin. Proc Natl Acad Sci U S A 101:
3468–3473.
4 3 .Z e n gF ,B a l d w i nD A ,S c h u l t zR M( 2 004) Transcript profiling during
preimplantation mouse development. Dev Biol 272: 483–496.
44. Vanhoutteghem A, Djian P (2006) Basonuclins 1 and 2, whose genes share
a common origin, are proteins with widely different properties and functions.
Proc Natl Acad Sci U S A 103: 12423–12428.
45. Swamynathan SK, Katz JP, Kaestner KH, Ashery-Padan R, Crawford MA, et
al. (2007) Conditional deletion of the mouse Klf4 gene results in corneal
epithelial fragility, stromal edema, and loss of conjunctival goblet cells. Mol Cell
Biol 27: 182–194.
46. Orsulic S, Huber O, Aberle H, Arnold S, Kemler R (1999) E-cadherin binding
prevents beta-catenin nuclear localization and beta-catenin/LEF-1-mediated
transactivation. J Cell Sci 112 (Pt 8): 1237–1245.
47. Orsulic S, Kemler R (2000) Expression of Eph receptors and ephrins is
differentially regulated by E-cadherin. J Cell Sci 113 (Pt 10): 1793–1802.
48. Zantek ND, Azimi M, Fedor-Chaiken M, Wang B, Brackenbury R, et al. (1999)
E-cadherin regulates the function of the EphA2 receptor tyrosine kinase. Cell
Growth Differ 10: 629–638.
49. Behrens J, Vakaet L, Friis R, Winterhager E, Van Roy F, et al. (1993) Loss of
epithelial differentiation and gain of invasiveness correlates with tyrosine
phosphorylation of the E-cadherin/beta-catenin complex in cells transformed
with a temperature-sensitive v-SRC gene. J Cell Biol 120: 757–766.
50. Yook JI, Li XY, Ota I, Fearon ER, Weiss SJ (2005) Wnt-dependent regulation of
the E-cadherin repressor snail. J Biol Chem 280: 11740–11748.
51. Tseng H (2006) Cell-type-specific regulation of RNA polymerase I transcription:
a new frontier. BioEssays 28 (7): 719–725.
52. Zhang Y, Muyrers JP, Testa G, Stewart AF (2000) DNA cloning by homologous
recombination in Escherichia coli. Nat Biotechnol 18: 1314–1317.
53. Qian J, Lavker RM, Tseng H (2006) Mapping ribosomal RNA transcription
activity in the mouse eye. Dev Dyn 235: 1984–1993.
54. Hanakawa Y, Matsuyoshi N, Stanley JR (2002) Expression of desmoglein 1
compensates for genetic loss of desmoglein 3 in keratinocyte adhesion. J Invest
Dermatol 119: 27–31.
Bnc1-Null Corneal Epithelium
PLoS ONE | www.plosone.org 12 October 2007 | Issue 10 | e1087